Co-Diagnostics
CODX | NASDAQ
$0.47
-$0.08 (-14.12%)
At close: Oct 27, 2026, 4:00 PM ET
-14.12%
(1D)Rating
Key Statistics
Market Data
Market Cap $3.27M
1D Range
0.45 0.56
52W Range
0.45 37.80
Valuation (TTM)
PE -0.02
PB 0.26
EV/EBITDA -0.03
Valuation (NTM)
Forward PE N/A
Forward PEG 0.00
Price Target $180.00
Cash Flow
FCF Yield -839.2%
SBC Adj. FCF Yield -876.6%
SBC Impact -4.5%
Margins
Gross Margin 8.1%
Operating Margin -4170.1%
FCF Margin -3808.0%
Growth (CAGR)
Revenue 3Y | 5Y -53.8% |
-62.4%
Dil EPS 3Y | 5Y 16.0% |
-47.3%
FCF 3Y | 5Y -3.5% |
-79.0%
Returns
ROA -283.6%
ROE -211.0%
ROIC -200.4%
Financial Health
Net Cash
$3.65M
Current Ratio 1.81
Interest Coverage 0.00
Dividends
Div Yield N/A
Payout Ratio N/A
FCF Payout Ratio N/A
Loading financial charts...
Profile
Co-Diagnostics, Inc. operates as a molecular diagnostics company that develops, manufactures, and sells reagents used for diagnostic tests that function through the detection and/or analysis of nuclei...
Sector Healthcare
Industry Biotechnology
Employees 115
IPO Date Jul 12, 2017
Website co-dx.com
Fiscal Year January - December
Latest News
No news articles available yet.
Analyst Summary
# of Analysts
2
Consensus
Hold
Price Target
$180.00
Upside
+38197.87%
Buy (1)
Hold (1)
Sell (0)
Add to Watchlist
Select watchlists to add or remove CODX